Assembly Biosciences, Inc. ã¯ãç±³åœã§èšåºæ®µéã®ãã€ãªãã¯ãããžãŒäŒæ¥ãšããŠäºæ¥ãå±éããŠããŸããå瀟ã¯ãB åèçãŠã€ã«ã¹ (HBV) ææçã®æ²»çã®ããã®çµå£æ²»çè¬åè£ãéçºããŠããŸãããã®è£œååè£ã«ã¯ãæ
¢æ§ HBV ææçã®æ£è
ãæ²»çããããã® Vebicorvirãæ
¢æ§ HBV ææçã®ç¬¬ II çžèšåºè©Šéšäžã® ABI-H2158ãHBV ã®æ²»çã®ç¬¬ Ia çžèšåºè©Šéšãå®äºãã ABI-H3733 ãªã©ããããŸããå瀟ã¯ãAllergan Pharmaceuticals International LimitedãBeiGene, Ltd.ãããã³ Arbutus Biopharma Corporation ãšååå¥çŽãçµãã§ããã»ããIndiana University Research and Technology Corporationãããã³ Door Pharmaceuticals, LLC ãšæŠç¥çã©ã€ã»ã³ã¹å¥çŽãçµãã§ããŸãããŸããæ
¢æ§ B åèçãŠã€ã«ã¹ææçã®æ£è
ã«å¯Ÿãã 3 å€äœµçšçæ³ãè©äŸ¡ãããããAntios Therapeutics, Inc. ãšèšåºååå¥çŽãçµãã§ããŸããå瀟ã¯ä»¥å㯠Ventrus Biosciences, Inc. ãšããŠç¥ãããŠããŸãããã2014 幎 6 æã« Assembly Biosciences, Inc. ã«ç€Ÿåã倿ŽããŸãããAssembly Biosciences, Inc. 㯠2005 幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµãŠã¹ãµã³ãã©ã³ã·ã¹ã³ã«æ¬ç€Ÿã眮ããŠããŸãã